MedKoo Cat#: 556328 | Name: Fmoc-Cit-PABA
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Fmoc-Cit-PABA is a peptide linker useful for drug conjugate synthesis or ADC synthesis.

Chemical Structure

Fmoc-Cit-PABA
Fmoc-Cit-PABA
CAS#870487-04-0

Theoretical Analysis

MedKoo Cat#: 556328

Name: Fmoc-Cit-PABA

CAS#: 870487-04-0

Chemical Formula: C28H30N4O5

Exact Mass: 502.2216

Molecular Weight: 502.57

Elemental Analysis: C, 66.92; H, 6.02; N, 11.15; O, 15.92

Price and Availability

Size Price Availability Quantity
100mg USD 350.00 2 Weeks
250mg USD 550.00 2 Weeks
500mg USD 950.00 2 Weeks
1g USD 1,650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Fmoc-Cit-PABA; Fmoc-Cit-PAB-OH; Fmoc Cit-PAB-OH; Fmoc-Cit-PAB OH
IUPAC/Chemical Name
(9H-fluoren-9-yl)methyl (S)-(1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)carbamate
InChi Key
KBTCNJJDJZRXCX-VWLOTQADSA-N
InChi Code
InChI=1S/C28H30N4O5/c29-27(35)30-15-5-10-25(26(34)31-19-13-11-18(16-33)12-14-19)32-28(36)37-17-24-22-8-3-1-6-20(22)21-7-2-4-9-23(21)24/h1-4,6-9,11-14,24-25,33H,5,10,15-17H2,(H,31,34)(H,32,36)(H3,29,30,35)/t25-/m0/s1
SMILES Code
O=C(N[C@H](C(NC1=CC=C(CO)C=C1)=O)CCCNC(N)=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 502.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Beck A, Goetsch L, Dumontet C, Corvaïa N. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337. doi: 10.1038/nrd.2016.268. Epub 2017 Mar 17. PMID: 28303026.